Morgan Stanley has nudged up its price target on Applied Aerospace & Defense to $24 from $23, even as the company's first quarterly report since its initial public offering came in below expectations on profitability and cash flow. The bank maintained its equal-weight rating, suggesting it sees the stock as fairly valued rather than a standout buy.
Applied Aerospace & Defense, which went public recently, designs and manufactures components for military and aerospace customers. Its debut quarter, covering the second quarter of the fiscal year, showed weaker-than-expected margins and cash generation, which typically raises red flags for investors. But Morgan Stanley believes the market may be overreacting to the "print," pointing to a steady stream of defense demand that could support future growth.
Why the bank is staying positive
The key driver, according to Morgan Stanley, is the company's C5ISR & Precision Strike segment. C5ISR stands for Command, Control, Communications, Computers, Cyber, Intelligence, Surveillance, and Reconnaissance—a mouthful that essentially covers the technology and systems that help militaries gather information, communicate, and strike targets with precision. This segment is expected to see more orders as large defense contractors convert broad missile agreements into specific contracts.
In the defense industry, prime contractors like Lockheed Martin or Raytheon often sign umbrella agreements with governments that outline a general scope of work. These agreements then get broken down into individual task orders or contracts, which flow down to suppliers like Applied Aerospace. Morgan Stanley's view is that this conversion process is still in its early stages, meaning Applied could see a pickup in orders as those contracts materialize.
The bank's confidence is not unique to this company. Across the defense sector, analysts have been highlighting the strength of military spending, particularly in areas like precision munitions and electronic warfare. For example, RBC recently named Thales a top European defense pick on a 15% growth outlook, and Elbit Systems reported a record backlog even as its aerospace sales dipped. These signals point to a broader trend of robust demand for defense technology.
What the weak Q2 numbers mean
Applied's second-quarter results showed lower-than-expected profitability and cash flow. For a newly public company, this can be concerning because investors often expect a strong start to justify the IPO valuation. However, Morgan Stanley suggests that the market's negative reaction may be too harsh, given the longer-term demand picture.
Cash flow is particularly important for defense suppliers because they often have to invest heavily in production capacity and inventory before orders are fulfilled. A weak cash flow quarter could be a timing issue rather than a fundamental problem. Similarly, margins can fluctuate based on the mix of products sold and the stage of production.
Investors should note that an equal-weight rating means Morgan Stanley is not recommending the stock as a top pick, but it also isn't advising clients to sell. The raised price target of $24 suggests the bank sees modest upside from current levels, but the stock is not expected to soar.
What it means for investors
For everyday investors, this story highlights a few key points. First, a single quarter's results, especially for a newly public company, may not tell the whole story. It's important to look at the underlying demand drivers and the company's position in the supply chain.
Second, defense spending is often seen as a stable, long-term source of demand, but it can be lumpy. Contracts can be delayed, and cash flows can vary. Investors should be prepared for volatility in this sector.
Third, price target changes by analysts are just one piece of information. They are based on models and assumptions that can change. It's wise to consider a range of opinions and do your own research before making investment decisions.
Morgan Stanley's move also comes amid a broader backdrop of rising defense budgets globally, driven by geopolitical tensions. This has been a tailwind for many defense contractors, and Morgan Stanley has also raised targets on other defense-related names like Axon, which makes law enforcement technology. The firm's view on Applied Aerospace seems to be that the company is well-positioned to benefit from these trends, even if its first quarter as a public company was not flawless.
Investors will likely watch for upcoming quarters to see if the expected order flow materializes and whether margins and cash flow improve. If the company can convert its pipeline into revenue, the stock could justify the higher target. If not, the equal-weight rating may prove optimistic.
In the meantime, the defense sector remains a focus for investors looking for growth in a market that is increasingly driven by technology and geopolitical factors. As always, diversification and a long-term perspective are key.
